← Open Payments lookup

CHELSEA BOHAC: Open Payments

NPI 1780108175 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$691 in 39 payments from 12 companies in 2025. Trend: 2023 $730 · 2024 $1,186 · 2025 $691

Food & beverage: $691
CompanyPaymentsAmount
ABBVIE INC.21$335
Novo Nordisk Inc4$81
Dexcom, Inc.2$55
Antares Pharma, Inc.2$36
AstraZeneca Pharmaceuticals LP2$33
SHIELD THERAPEUTICS INC2$31
GlaxoSmithKline, LLC.1$25
Otsuka America Pharmaceutical, Inc.1$25
Esperion Therapeutics, Inc.1$23
Lundbeck LLC1$16

Products named: VRAYLAR, UBRELVY, Ozempic, Dexcom G6 Transmitter, XYOSTED, ACCRUFER, TRELEGY ELLIPTA, REXULTI.

Industry payments across TX — which companies pay providers there.